NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

No, just that financial markets and coverage of them and companies in them is very carefully managed by papers and major media to avoid promoting things that may not be reliable. They'd happily promote Dr. Liau and UCLA. But honestly, it seems like Duke is perhaps better at self-promotion than UCLA. There is a lot of noise in the US as well. Many, many companies claiming that they have "The Answer". Media are terrible distinguishing them from one another. They'll tell just about any story. But say "penny stock" and that's a deal killer in terms of certain kinds of reporting. And even then, like I said, you have plenty of companies that are NOT penny stocks and the coverage focuses on the doctors, patients and trial without often mentioning the company names. Science reports are seen differently. But, often it is hard to get the attention of general media. Science media, as I said, will cover. And we saw LOTS of reports in science media about the clinical trial. But those are not general interest media, which means your dad or uncle or mom, aunt or sister is not going to likely hear about it unless they happen to read very narrow science coverage in industry related media typically.

I will note that there was surprisingly less coverage of the Phase 3 JAMA publication in the UK media than the interim results publication. So the US is not unique. I did not see it in Canada, and I'd expect that we'd have heard about German coverage if it had occurred. So the US is not unique. It's just the nature of things. Some stories are too complicated for major media to really parse what is significant and what is not and without approval and more news of patients living long with GBM, you're probably not going to see a lot of curious journalists promoting the story.